Search - tctmd.com

Displaying 301 - 320 of 389

Sort: Relevancy | Date

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Industry News

New Study Results Show High Survival Rates and Improved Quality of Life for Patients with Medtronic CoreValve® System

October 22, 2012

News Industry News

FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study

October 22, 2012

News Industry News

First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect

October 19, 2012

News Industry News

FDA expands approved use of Sapien artificial heart valve

October 19, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve System

October 02, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Industry News

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

August 26, 2012

News Industry News

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

July 18, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

News Industry News

Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program

June 21, 2012

Advertisement

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

New Study Results Show High Survival Rates and Improved Quality of Life for Patients with Medtronic CoreValve® System

FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study

First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect

FDA expands approved use of Sapien artificial heart valve

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

New Data Reinforce Positive Clinical Outcomes for Direct Aortic Implants Using the Medtronic CoreValve System

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Boston Scientific WATCHMAN® Left Atrial Appendage Closure Device Receives CE Mark Approval For Expanded Use

Medtronic Begins Global Clinical Trial Evaluating CoreValve® System Implantation in Intermediate-Risk Patients

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Medtronic Stent Graft Chosen by U.S. FDA for Innovative Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content